These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17052055)

  • 21. Association of healthcare barriers with prostate-specific antigen screening among African-American and Afro-Caribbean men.
    Lee DJ; Consedine NS; Gonzalez JR; Spencer BA
    Urology; 2012 Sep; 80(3):556-63. PubMed ID: 22789295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma.
    Mistry K; Cable G
    J Am Board Fam Pract; 2003; 16(2):95-101. PubMed ID: 12665174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity and prostate cancer screening among African-American and Caucasian men.
    Fowke JH; Signorello LB; Underwood W; Ukoli FA; Blot WJ
    Prostate; 2006 Sep; 66(13):1371-80. PubMed ID: 16752375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer screening parameters in a high-risk African-Caribbean population.
    Bunker CH; Patrick AL; Miljkovic-Gacic I; Konety BR; Belle A; Richard JR; Dhir R
    Urology; 2004 Apr; 63(4):737-41. PubMed ID: 15072891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population screening for prostate cancer and emerging concepts for young men.
    Moul JW
    Clin Prostate Cancer; 2003 Sep; 2(2):87-97. PubMed ID: 15040869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate-specific antigen concentration in young men: new estimates and review of the literature.
    Sutcliffe S; Pakpahan R; Sokoll LJ; Elliott DJ; Nevin RL; Cersovsky SB; Walsh PC; Platz EA
    BJU Int; 2012 Dec; 110(11):1627-35. PubMed ID: 22502603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physician-patient discussions with african american men about prostate cancer screening.
    Ross LE; Powe BD; Taylor YJ; Howard DL
    Am J Mens Health; 2008 Jun; 2(2):156-64. PubMed ID: 19477779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
    Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
    BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pros and cons of prostate cancer screening: associations with screening knowledge and attitudes among urban African American men.
    Davis SN; Diefenbach MA; Valdimarsdottir H; Chen T; Hall SJ; Thompson HS
    J Natl Med Assoc; 2010 Mar; 102(3):174-82. PubMed ID: 20355346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recruitment strategies and comparison of prostate cancer-specific clinical data on African-American and Caucasian males with and without family history.
    Mandal DM; Sartor O; Halton SL; Mercante DE; Bailey-Wilson JE; Rayford W
    Prostate Cancer Prostatic Dis; 2008; 11(3):274-9. PubMed ID: 18268528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate cancer screening in younger men: prostate-specific antigen and public awareness.
    Moon TD; Clejan S
    Urology; 1991 Sep; 38(3):216-9. PubMed ID: 1716022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low AUA symptom score independently predicts positive prostate needle biopsy: results from a racially diverse series of 411 patients.
    Porter CR; Kim J
    Urology; 2004 Jan; 63(1):90-4. PubMed ID: 14751356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early detection of prostate cancer in African-American men through use of multiple biomarkers: human kallikrein 2 (hK2), prostate-specific antigen (PSA), and free PSA (fPSA).
    Martin BJ; Finlay JA; Sterling K; Ward M; Lifsey D; Mercante D; Jainto JM; Martin L; Rayford W
    Prostate Cancer Prostatic Dis; 2004; 7(2):132-7. PubMed ID: 15007379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
    Agalliu I; Weiss NS; Lin DW; Stanford JL
    Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
    Tasian GE; Cooperberg MR; Cowan JE; Keyashian K; Greene KL; Daniels NA; Carroll PR; Chan JM
    Urol Oncol; 2012; 30(2):155-60. PubMed ID: 20800514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
    Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
    Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attitudes and practices of primary care physicians for prostate cancer screening.
    Hoffman RM; Papenfuss MR; Buller DB; Moon TE
    Am J Prev Med; 1996; 12(4):277-81. PubMed ID: 8874692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
    Bunting PS; Goel V; Williams JI; Iscoe NA
    CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate-specific antigen testing among the elderly in community-based family medicine practices.
    Hudson SV; Ohman-Strickland P; Ferrante JM; Lu-Yao G; Orzano AJ; Crabtree BF
    J Am Board Fam Med; 2009; 22(3):257-65. PubMed ID: 19429731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
    Schröder FH; van der Maas P; Beemsterboer P; Kruger AB; Hoedemaeker R; Rietbergen J; Kranse R
    J Natl Cancer Inst; 1998 Dec; 90(23):1817-23. PubMed ID: 9839522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.